Concepedia

Kenji Kita

KK

32

Publications

1.3K

Citations

22

H-Index

1999

Active since

Affiliations

Kanazawa University(Current)

Eisai (Japan)

Life Science Institute

Nisshin Seifun Group (Japan)

Tokushima University

Kenji Kita is an author at Kanazawa University specializing in medicine, tumor biology, and lung cancer.

ORCID

Top concepts

Publications per year

1999–2024

32

Publications

32

Paracrine Receptor Activation by Microenvironment Triggers Bypass Survival Signals and ALK Inhibitor Resistance in EML4-ALK Lung Cancer Cells

Tadaaki Yamada, Shinji Takeuchi, Junya Nakade et al. · Clinical Cancer Research · 2012 · 116 citations

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer

Rong Wang, Tadaaki Yamada, Kenji Kita et al. · Nature Communications · 2020 · 112 citations · Full text

Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2

Tatsunori Nishimura, Asuka Nakata, Xiaoxi Chen et al. · Oncogene · 2018 · 106 citations · Full text

Combined Therapy with Mutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in <i>EGFR</i> -Mutant Lung Cancer

Takayuki Nakagawa, Shinji Takeuchi, Tadaaki Yamada et al. · Molecular Cancer Therapeutics · 2012 · 80 citations · Full text

Hematocrit-Independent Recovery is A Key for Bioanalysis Using Volumetric Absorptive Microsampling Devices, Mitra <sup>Tm</sup>

Yuji Mano, Kenji Kita, Kazutomi Kusano · Bioanalysis · 2015 · 70 citations

Rows per page

1–5 of 32